Le Lézard
Classified in: Science and technology
Subjects: PDT, MAT

Surfside Introduces Real-Time Ecommerce Attribution for Cannabis Media Measurement


NEW YORK, Jan. 18, 2022 /PRNewswire/ -- Surfside Solutions Inc. ("Surfside"), an end-to-end marketing technology that aggregates first-party data across all customer touchpoints, today announced the launch of real-time ecommerce measurement to the Surfside Attribution Platform, a self-service measurement tool that allows dispensaries, brands and delivery companies the ability to visualize online sales that are directly attributed to their digital and traditional media campaigns. 

The addition of ecommerce measurement to Surfside's Attribution Platform allows customers to visualize campaign metrics, store visitation and ecommerce sales in one single view. Real-time ecommerce attribution combined with retail foot traffic measurement provides advertisers with a complete picture of the path to purchase, offering transparency and insight to aid in better media optimization decisions.

"Our biggest goal at Surfside is to turn first-party data into an asset for media performance and sales for our advertisers," says Michael Blanche, co-founder at Surfside. "By clearly visualizing exactly which channels, ad creative and audiences are driving the strongest return on ad spend, real-time ecommerce attribution allows our clients to use their own sales data to improve the performance of their marketing initiatives." 

With the addition of real-time ecommerce attribution, users can:

As customer journeys get more complex and attribution gets more crucial than ever, Surfside continues to build best-in-class reporting to give advertisers the control they need to understand ad performance alongside overall business metrics. By offering a truly real-time view of ecommerce sales and return on ad spend in a single dashboard, real-time ecommerce attribution makes advertising with Surfside as transparent as possible.

ABOUT SURFSIDE

Surfside is an end-to-end marketing technology that aggregates first-party data across all customer touchpoints, allowing advertisers the ability to better understand, target, and measure how to influence current and future customers. Powered by the only cannabis-focused customer data platform (CDP) with a complete view and opinion on the cannabis consumer, Surfside enables cannabis businesses to find and attract qualified consumers through the monetization of their online and in-store audiences.

Media Contact:

Scott Cianciulli
The Plunkett Group
(212) 739-6753
[email protected]

Related Links

https://www.surfside.io

SOURCE Surfside Solutions Inc.


These press releases may also interest you

at 09:05
Aspen Technology, Inc. , a global leader in industrial software, today introduced AspenTech Strategic Planning for Sustainability Pathwaystm ? a new and unique integrated modelling and optimization solution that aims to guide companies in carbon...

at 09:00
Dental Care Acworth is thrilled to utilize this remarkable innovation and offer patients unbiased, objective and standardized dental care that they know they can trust. The AI solutions Pearl delivers can assist dental...

at 09:00
The Ceph Foundation, the global community dedicated to fostering the growth and advancement of Ceph, is excited to announce the release of Ceph Squid, which comes with several performance and space efficiency features along with enhanced protocol...

at 09:00
Amgen today announced the imminent submission of a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for teprotumumab, a fully human monoclonal antibody and targeted inhibitor of the insulin-like growth factor-1...

at 09:00
RapidScale, a Cox Business company, bolsters its cybersecurity offerings with SOC as a Service that includes Managed Detection and Response (MDR), a cutting-edge security solution powered by Proficio. This strategic partnership reinforces...

at 09:00
Ractigen Therapeutics, a leader in the development of small activating RNA (saRNA) therapeutics, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational New Drug (IND) application for RAG-01, a...



News published on and distributed by: